Nanopore Sequencing of Cell-Free DNA as a Biomarker for ALL, Frontiers in Oncology (2022)
Acute Lymphoblastic Leukemia (ALL) is a common type of cancer primarily affecting children. Unfortunately, patients who experience a relapse of ALL tend to have a poor prognosis. Detecting any remaining cancer cells, called minimal residual disease (MRD), and identifying its…
